Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Amortization - Intangibles (2021 - 2024)

PAVmed has reported Amortization - Intangibles over the past 4 years, most recently at $105000.0 for Q2 2024.

  • Quarterly results put Amortization - Intangibles at $105000.0 for Q2 2024, down 79.21% from a year ago — trailing twelve months through Dec 2024 was $982000.0 (down 51.39% YoY), and the annual figure for FY2024 was $559000.0, down 72.34%.
  • Amortization - Intangibles for Q2 2024 was $105000.0 at PAVmed, down from $372000.0 in the prior quarter.
  • Over the last five years, Amortization - Intangibles for PAVM hit a ceiling of $650000.0 in Q2 2022 and a floor of $17000.0 in Q3 2021.
  • Median Amortization - Intangibles over the past 4 years was $505000.0 (2022), compared with a mean of $368416.7.
  • Biggest five-year swings in Amortization - Intangibles: skyrocketed 2870.59% in 2022 and later crashed 79.21% in 2024.
  • PAVmed's Amortization - Intangibles stood at $123000.0 in 2021, then soared by 311.38% to $506000.0 in 2022, then decreased by 0.2% to $505000.0 in 2023, then crashed by 79.21% to $105000.0 in 2024.
  • The last three reported values for Amortization - Intangibles were $105000.0 (Q2 2024), $372000.0 (Q1 2024), and $505000.0 (Q4 2023) per Business Quant data.